Page 17 - Immunizations News Today

Company sees full-year COVID sales of $6 billion to $8 billion but says size of U.S. market is still uncertain

Cost-saving program "will touch all parts of the business" but won't affect Seagen acquisition, Pfizer says.

By Ben Glickman Pfizer said it would reverse $4.2 billion in revenue after revising its agreement with the U.S. government related to its Covid-19 treatment...

The deal covering about 85,000 unionized workers offer raises and promises of increased staffing after historic worker walkout, but the details must still be ratified by union members.

The maternal RSV vaccine will significantly reduce infant hospitalizations and curb medical costs, finds a new modeling study exploring the benefit of widespread use.

The treatment is one of a number of new products that the company expects to bring in a combined $20 billion in potential annual revenue by 2030.

The drug-store giant will close some less profitable stores as it looks to cut costs by at least $1 billion.

The European Union, Gates Foundation, and the European Investment Bank have announced a new financing package of more than 1 billion euros ($1.06 billion) to eradicate polio.

By Chris Wack Ocugen shares were up 9% at 45 cents after the company said the National Institute of Allergy and Infectious Diseases, a part of the National...

By Michael Susin GSK said that Chongqing Zhifei Biological Products has agreed to purchase the company's shingles vaccine Shingrix under an exclusive...